Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Cabozantinib-S-Malate in Treating Patients With Advanced Solid Tumors and Human Immunodeficiency Virus

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2016 by National Cancer Institute (NCI)
Information provided by (Responsible Party):
National Cancer Institute (NCI) Identifier:
First received: April 1, 2013
Last updated: September 16, 2016
Last verified: September 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: April 2017 (Final data collection date for primary outcome measure)